| |
t-tau
|
p-tau
|
Abeta42
|
Abeta40
|
|---|
|
AD
|
|
rho
|
−0.098
|
−0.112
|
0.182
|
0.070
|
|
95% CI
|
−0.332 to 0.147
|
−0.344 to 0.134
|
−0.406 to 0.062
|
−0.193 to 0.323
|
|
p-value
|
0.420
|
0.358
|
0.131
|
0.592
|
|
VaD
|
|
rho
|
0.281
|
−0.141
|
−0.030
| |
|
95% CI
|
−0.114 to 0.600
|
−0.517 to 0.280
|
−0.438 to 0.389
|
n.a.
|
|
p-value
|
0.147
|
0.501
|
0.891
| |
|
LBD
|
|
rho
|
0.078
|
−0.119
|
−0.296
| |
|
95% CI
|
−0.233 to 0.374
|
−0.444 to 0.233
|
−0.560 to 0.022
|
n.a.
|
|
p-value
|
0.617
|
0.495
|
0.060
| |
|
CJD
|
|
rho
|
−0.028
|
−0.071
|
0.105
| |
|
95% CI
|
−0.247 to 0.103
|
−0.372 to 0.243
|
−0.168 to 0.362
|
n.a.
|
|
p-value
|
0.798
|
0.651
|
0.439
| |
|
FTD
|
|
rho
|
−0.041
|
−0.148
|
0.031
| |
|
95% CI
|
(−0.411 to 0.341)
|
−0.54 to 0.316
|
−0.388 to 0.439
|
n.a.
|
|
p-value
|
0.832
|
0.522
|
0.887
| |
- Correlation coefficient (rho), 95% confidence interval (95% CI), and p-values from non-parametric spearman correlations are indicated
- AD Alzheimer’s disease, VaD Vascular dementia, LBD Lewy body diseases, CJD Creutzfeldt-Jakob disease, FTD Fronto-temporal dementia, t-Tau CSF Total tau protein, p-tau CSF Phosphorylated tau protein, Abeta42 CSF beta-amyloid 1-42, Abeta40 CSF beta-amyloid 1-40
